メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

A case of anaphylaxis from cefatrizine propylene glycolate (Cefrachol® dry syrup)

研究成果: ジャーナルへの寄稿学術論文査読

抄録

We report a case of anaphylaxis of cefatrizine propylene glycolate. A 5-year-old female consulted a local clinic because of her symptoms of common cold on December 10, 2001. She developed dyspnea, generalized wheals, abdominal pain, and urinary incontinence 5 minutes after she took an antibiotics (Cefrachol® dry syrup) and a mixed syrup of lysozyme chloride, chlorpheniramine-maleate, dihydrocodeine phosphate, ephedrine hydrochloride and ambroxol hydrochloride that was prescribed by the physician. She was carried to our clinic by an ambulance. These symptoms were improved with medication of epinephrine and a corticosteroid. We performed a skin test with the drugs prescribed by the local clinic physician on January 4, 2002. Cefrachol® dry syrup resulted in a positive reaction with itchy wheal by open test. Skin testing with the components of Cefrachol® dry syrup on January 25, 2002. She showed a positive itchy wheal reaction to cefatrizine propylene glycolate. Therefore we diagnosed her as having anaphylaxis from cefatrizine propylene glycolate. The drug eruption from cefatrizine propylene glycolate has been reported in 27 cases including 2 cases of anaphylaxis. We found out some antibiotics that she could take, and could ease her mother mind.

本文言語英語
ページ(範囲)172-175
ページ数4
ジャーナルSkin Research
1
3
出版ステータス出版済み - 06-2002

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 皮膚病学
  • 感染症

フィンガープリント

「A case of anaphylaxis from cefatrizine propylene glycolate (Cefrachol® dry syrup)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル